The FDA and Pfizer said they are waiting on data about the effectiveness and safety of a third dose, which won’t come until April.
Dr. Paul Offit said the fast-track plan was based on the assumption that the third dose would prove safe and effective, but there’s no guarantee that will be the case.
https://www.cnbc.com/2022/02/12/covid-fd...fails.html
Dr. Paul Offit said the fast-track plan was based on the assumption that the third dose would prove safe and effective, but there’s no guarantee that will be the case.
https://www.cnbc.com/2022/02/12/covid-fd...fails.html